Differences

This shows you the differences between two versions of the page.

--- covid-19_therapeutics_task_force [2023/04/29 19:28]
liam [Members]
+++ covid-19_therapeutics_task_force [2023/04/30 06:47] (current)
liam [History]
@@ Line 3: / Line 3: @@
 The **COVID-19 Therapeutics Task Force** was a Canadian public-private advisory body convened by [[Innovation, Science and Economic Development Canada]] (ISED).((Innovation, Science and Economic Development Canada. (2022, March 10). //COVID-19 Therapeutics Task Force.// Government of Canada. http://archive.today/2023.04.27-230206/https://ised-isde.canada.ca/site/canadian-life-science-industries/en/covid-19-therapeutics-task-force))
+===== History =====
+[[Navdeep Bains]], Minister of Innovation, Science and Industry, announced the membership of the COVID-19 Therapeutics Task Force on August 5, 2020.((Jagric, A., Roy, C., Innovation, Science and Economic Development Canada, & Public Services and Procurement Canada. (2020, August 5). //Government of Canada announces major steps in treating and preventing COVID-19 through vaccines and therapies.// Government of Canada. http://archive.today/2022.12.16-235932/https://www.canada.ca/en/innovation-science-economic-development/news/2020/08/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies.html)) Bains also announced the membership of the [[COVID-19 Vaccine Task Force]].
 ===== Members =====
@@ Line 22: / Line 25: @@
 | [[Samira Mubareka]]  | Advisor  | [[Sunnybrook Health Sciences Centre]], [[University of Toronto]], [[Centre for Research Expertise in Occupational Disease]] (CREOD), [[Canadian COVID-19 Genomics Network]] (CanCOGen), [[Genome Canada]], [[Ontario's COVID-19 Genomics Rapid Response Coalition]] (ONCoV), [[Ontario Academic Health Sciences SARS-CoV-2 Sequencing Network]] (ONS2), [[Sunnybrook Translational Research Group for Emerging Respiratory Viruses]] (SERV)  |
 | [[Pamela Ohashi]]  | Advisor  | [[Princess Margaret Cancer Centre]], [[University of Toronto]], [[American Association for Cancer Research]] (AACR), [[Society for Immunotherapy of Cancer]] (SITC), [[Royal Society of Canada]] (RSC)  |
+| [[James Russell]]  | Advisor  | [[University of British Columbia]] (UBC), [[Centre for Heart Lung Innovation]] (HLI), [[Sirius Genomics]], [[pharmaceutical_companies:Cyon Therapeutics]], [[St. Paul's Hospital]]  |
+| [[Makeda Semret]]  | Advisor  | [[McGill University Health Centre]] (MUHC), [[Joint Programming Initiative on Antimicrobial Resistance]] (JPIAMR), [[AAU-McGill Partnership for Infectious Diseases]] (AMP-ID)  |
+| [[Don Sheppard]]  | Advisor  | [[McGill University Health Centre]] (MUHC), [[McGill Interdisciplinary Initiative in Infection and Immunity]] (MI4)  |
+| [[Don Vinh]]  | Advisor  | [[McGill University Health Centre]] (MUHC), [[Canadian Glycomics Network]] (GlycoNet), [[Association of Medical Microbiology and Infectious Disease Canada]] (AMMI), [[Clinical Immunology Society]] (CIS), [[Comité consultatif québécois pour les maladies rares]], [[MUHC COVID-19 Biobank]], [[COVID-19 and Cancer Consortium]] (CCC19), [[COVID Human Genetic Effort]] (CHGE)  |
+===== External links =====
+  * [[http://covidtruthinitiative.ca/Organizations/COVID-19-Therapeutics-Task-Force|COVID Truth Initiative]]